Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes-Reference-Cited by-同舟云学术

Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes

Published:2014-07-10 Issue:2 Volume:124 Page:211-219
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Scully Marie¹,Thomas Mari²,Underwood Mary²,Watson Henry³,Langley Katherine²,Camilleri Raymond S.⁴,Clark Amanda⁵,Creagh Desmond⁶,Rayment Rachel⁷,Mcdonald Vickie⁸,Roy Ashok⁹,Evans Gillian¹⁰,McGuckin Siobhan¹,Ni Ainle Fionnuala¹¹,Maclean Rhona¹²,Lester William¹³,Nash Michael¹⁴,Scott Rosemary¹,O Brien Patrick¹,

Affiliation:

1. University College London Hospitals, London, United Kingdom;

2. University College London, London, United Kingdom;

3. Aberdeen Royal Infirmary, Aberdeen, United Kingdom;

4. University of Westminster, London, United Kingdom;

5. University Hospitals Bristol National Health Service Foundation Trust, Bristol, United Kingdom;

6. Royal Cornwall Hospital Trust, Cornwall, United Kingdom;

7. Cardiff and Vale University Hospital, Cardiff, United Kingdom;

8. Guy’s and St. Thomas’ National Health Service Foundation Trust, London, United Kingdom;

9. Basingstoke and North Hampshire National Health Service Trusts, Basingstoke, Hampshire, United Kingdom;

10. Kent and Canterbury Hospitals, Canterbury, Kent, United Kingdom;

11. The Rotunda Hospital, Dublin, Ireland;

12. Sheffield Teaching Hospital National Health Service Trust, Sheffield, United Kingdom;

13. University Hospital Birmingham, Birmingham, United Kingdom; and

14. Manchester Royal Infirmary, Manchester, United Kingdom

Abstract

Key Points In women presenting with an initial diagnosis of TTP during pregnancy, cTTP was more common than acquired TTP. Active monitoring and management during pregnancy results in positive pregnancy outcomes.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/2/211/1381106/211.pdf

Reference28 articles.

1. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family.;Fujikawa;Blood,2001

2. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.;Levy;Nature,2001

3. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features.;Scully;Br J Haematol,2008

4. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.;Camilleri;J Thromb Haemost,2008

5. A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom.;Camilleri;J Thromb Haemost,2012

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HELLP Syndrome and Differential Diagnosis with Other Thrombotic Microangiopathies in Pregnancy;Diagnostics;2024-02-06

2. Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsia;Journal of Thrombosis and Haemostasis;2024-02

3. Successful management of refractory immune‐mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti‐VWF nanobody caplacizumab;British Journal of Haematology;2024-01-02

4. Thrombotic thrombocytopenic purpura;The Brain of the Critically Ill Pregnant Woman;2024

5. Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience;Blood Advances;2023-12-29